Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 98

1.

Thiotepa, busulfan and fludarabine compared to busulfan and cyclophosphamide as conditioning regimen for allogeneic stem cell transplant from matched siblings and unrelated donors for acute myeloid leukemia.

Saraceni F, Beohou E, Labopin M, Arcese W, Bonifazi F, Stepensky P, Aljurf M, Bruno B, Pioltelli P, Passweg J, Sociè G, Santarone S, Yakoub-Agha I, Lanza F, Savani BN, Mohty M, Nagler A; Acute Leukemia Working Party (ALWP) of the European Society for Blood and Marrow Transplantation (EBMT).

Am J Hematol. 2018 Jul 23. doi: 10.1002/ajh.25225. [Epub ahead of print]

PMID:
30033639
2.

Killer cell immunoglobulin-like receptor ligand mismatching and outcome after haploidentical transplantation with post-transplant cyclophosphamide.

Shimoni A, Labopin M, Lorentino F, Van Lint MT, Koc Y, Gülbas Z, Tischer J, Bruno B, Blaise D, Pioltelli P, Afanasyev B, Ciceri F, Mohty M, Nagler A.

Leukemia. 2018 Jun 15. doi: 10.1038/s41375-018-0170-5. [Epub ahead of print]

PMID:
29907809
3.

Long-term and low-dose of busulfan is a safe and effective second-line treatment in elderly patients with essential thrombocythemia resistant or intolerant to hydroxyurea.

Renso R, Aroldi A, Pioltelli P, Gambacorti-Passerini C, Elli EM.

Blood Cancer J. 2018 Jun 11;8(6):56. doi: 10.1038/s41408-018-0091-6. No abstract available.

4.

Impact of extramedullary disease in patients with newly diagnosed multiple myeloma undergoing autologous stem cell transplantation: a study from the Chronic Malignancies Working Party of the EBMT.

Gagelmann N, Eikema DJ, Iacobelli S, Koster L, Nahi H, Stoppa AM, Masszi T, Caillot D, Lenhoff S, Udvardy M, Crawley C, Arcese W, Mariette C, Hunter A, Leleu X, Schipperus M, Delforge M, Pioltelli P, Snowden JA, Itälä-Remes M, Musso M, van Biezen A, Garderet L, Kröger N.

Haematologica. 2018 May;103(5):890-897. doi: 10.3324/haematol.2017.178434. Epub 2018 Feb 1.

5.

Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT.

Cesaro S, Crocchiolo R, Tridello G, Knelange N, Van Lint MT, Koc Y, Ciceri F, Gülbas Z, Tischer J, Afanasyev B, Bruno B, Castagna L, Blaise D, Mohty M, Irrera G, Diez-Martin JL, Pierelli L, Pioltelli P, Arat M, Delia M, Fagioli F, Ehninger G, Aljurf M, Carella AM, Ozdogu H, Mikulska M, Ljungman P, Nagler A, Styczynski J.

Bone Marrow Transplant. 2018 Apr;53(4):422-430. doi: 10.1038/s41409-017-0016-1. Epub 2018 Jan 12.

PMID:
29330396
6.

Predicting failure of hematopoietic stem cell mobilization before it starts: the predicted poor mobilizer (pPM) score.

Olivieri J, Attolico I, Nuccorini R, Pascale SP, Chiarucci M, Poiani M, Corradini P, Farina L, Gaidano G, Nassi L, Sica S, Piccirillo N, Pioltelli PE, Martino M, Moscato T, Pini M, Zallio F, Ciceri F, Marktel S, Mengarelli A, Musto P, Capria S, Merli F, Codeluppi K, Mele G, Lanza F, Specchia G, Pastore D, Milone G, Saraceni F, Di Nardo E, Perseghin P, Olivieri A.

Bone Marrow Transplant. 2018 Apr;53(4):461-473. doi: 10.1038/s41409-017-0051-y. Epub 2018 Jan 12.

PMID:
29330395
7.

Relatively favorable outcome after allogeneic stem cell transplantation for BCR-ABL1-positive AML: A survey from the acute leukemia working party of the European Society for blood and marrow transplantation (EBMT).

Lazarevic VL, Labopin M, Depei W, Yakoub-Agha I, Huynh A, Ljungman P, Schaap N, Cornelissen JJ, Maillard N, Pioltelli P, Gedde-Dahl T, Lenhoff S, Houhou M, Esteve J, Mohty M, Nagler A.

Am J Hematol. 2018 Jan;93(1):31-39. doi: 10.1002/ajh.24928. Epub 2017 Oct 31.

PMID:
28971504
8.

HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC).

Galli M, Oreni L, Saccardo F, Castelnovo L, Filippini D, Marson P, Mascia MT, Mazzaro C, Origgi L, Ossi E, Pietrogrande M, Pioltelli P, Quartuccio L, Scarpato S, Sollima S, Riva A, Fraticelli P, Zani R, Giuggioli D, Sebastiani M, Sarzi Puttini P, Gabrielli A, Zignego AL, Scaini P, Ferri C, De Vita S, Monti G.

Clin Exp Rheumatol. 2017 Mar-Apr;35 Suppl 103(1):67-76. Epub 2017 Apr 19.

9.

Decision analysis of allogeneic hematopoietic stem cell transplantation for patients with myelodysplastic syndrome stratified according to the revised International Prognostic Scoring System.

Della Porta MG, Jackson CH, Alessandrino EP, Rossi M, Bacigalupo A, van Lint MT, Bernardi M, Allione B, Bosi A, Guidi S, Santini V, Malcovati L, Ubezio M, Milanesi C, Todisco E, Voso MT, Musto P, Onida F, Iori AP, Cerretti R, Grillo G, Molteni A, Pioltelli P, Borin L, Angelucci E, Oldani E, Sica S, Pascutto C, Ferretti V, Santoro A, Bonifazi F, Cazzola M, Rambaldi A.

Leukemia. 2017 Nov;31(11):2449-2457. doi: 10.1038/leu.2017.88. Epub 2017 Mar 21.

10.

Autologous hematopoietic stem cell transplantation for intravascular large B-cell lymphoma: the European Society for Blood and Marrow Transplantation experience.

Meissner J, Finel H, Dietrich S, Boumendil A, Kanfer E, Laboure G, Abecasis M, Cornelissen J, Delage J, Finke J, Hess U, Ludwig H, Mohty M, Pabst T, Pioltelli P, Robinson S, Samaras P, Montoto S, Dreger P.

Bone Marrow Transplant. 2017 Apr;52(4):650-652. doi: 10.1038/bmt.2016.339. Epub 2016 Dec 19. No abstract available.

PMID:
27991887
11.

Clinical Effects of Driver Somatic Mutations on the Outcomes of Patients With Myelodysplastic Syndromes Treated With Allogeneic Hematopoietic Stem-Cell Transplantation.

Della Porta MG, Gallì A, Bacigalupo A, Zibellini S, Bernardi M, Rizzo E, Allione B, van Lint MT, Pioltelli P, Marenco P, Bosi A, Voso MT, Sica S, Cuzzola M, Angelucci E, Rossi M, Ubezio M, Malovini A, Limongelli I, Ferretti VV, Spinelli O, Tresoldi C, Pozzi S, Luchetti S, Pezzetti L, Catricalà S, Milanesi C, Riva A, Bruno B, Ciceri F, Bonifazi F, Bellazzi R, Papaemmanuil E, Santoro A, Alessandrino EP, Rambaldi A, Cazzola M.

J Clin Oncol. 2016 Sep 6. pii: JCO673616. [Epub ahead of print]

12.

Asymptomatic central pontine myelinolysis without hyponatriemia in diffuse large B cell lymphoma.

Doni E, Tremolizzo L, Patassini M, Pioltelli PE, Ferrarese C, Appollonio I.

Neurol Sci. 2016 Dec;37(12):2035-2037. Epub 2016 Aug 3. No abstract available.

PMID:
27488303
13.

Severe, reversible nelarabine-induced neuropathy and myelopathy.

Alberti P, Parma M, Pioltelli P, Pogliani EM, Terruzzi E, Stasia A, Doni E, Cecchetti C, Cavaletti G.

J Peripher Nerv Syst. 2016 Sep;21(3):154-6. doi: 10.1111/jns.12173. No abstract available.

PMID:
27117493
14.

Retreatment regimen of rituximab monotherapy given at the relapse of severe HCV-related cryoglobulinemic vasculitis: Long-term follow up data of a randomized controlled multicentre study.

Quartuccio L, Zuliani F, Corazza L, Scaini P, Zani R, Lenzi M, Tavoni A, Sebastiani M, Baldovino S, Urraro T, Saccardo F, Sbreglia C, Mazzaro C, Pioltelli P, Fraticelli P, Filippini D, Gabrielli A, Perrella O, Scarpato S, Roccatello D, Zignego AL, Ferri C, Bombardieri S, Pietrogrande M, Monti G, Galli M, De Vita S.

J Autoimmun. 2015 Sep;63:88-93. doi: 10.1016/j.jaut.2015.07.012. Epub 2015 Aug 5.

15.

Neurological symptoms in essential thrombocythemia: impact of JAK2V617F mutation and response to therapy.

Aroldi A, Cecchetti C, Colombo A, Cattaneo L, Pioltelli PE, Pogliani EM, Elli EM.

Eur J Haematol. 2016 Jun;96(6):593-601. doi: 10.1111/ejh.12638. Epub 2015 Aug 20.

PMID:
26205460
16.

Good Outcome for Very High Risk Adult B-cell Acute Lymphoblastic Leukaemia Carrying Genetic Abnormalities t(4;11)(q21;q23) or t(9;22)(q34;q11), if Promptly Submitted to Allogeneic Transplantation, after Obtaining a Good Molecular Remission.

Parma M, Viganò C, Fumagalli M, Colnaghi F, Colombo A, Mottadelli F, Rossi V, Elli E, Terruzzi E, Belotti A, Cazzaniga G, Pogliani EM, Pioltelli P.

Mediterr J Hematol Infect Dis. 2015 Jun 1;7(1):e2015041. doi: 10.4084/MJHID.2015.041. eCollection 2015.

17.

Correction: Genetic Diversity of the KIR/HLA System and Susceptibility to Hepatitis C Virus-Related Diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Beretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 May 15;10(5):e0128849. doi: 10.1371/journal.pone.0128849. eCollection 2015. No abstract available.

18.

Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.

De Re V, Caggiari L, De Zorzi M, Repetto O, Zignego AL, Izzo F, Tornesello ML, Buonaguro FM, Mangia A, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Vaccher E, Berretta M, Mazzaro C, Libra M, Gini A, Zucchetto A, Cannizzaro R, De Paoli P.

PLoS One. 2015 Feb 20;10(2):e0117420. doi: 10.1371/journal.pone.0117420. eCollection 2015. Erratum in: PLoS One. 2015;10(5):e0128849. Beretta, Massimiliano [corrected to Berretta, Massimiliano].

19.

Peripheral blood lymphocyte/monocyte ratio predicts outcome in follicular lymphoma and in diffuse large B-cell lymphoma patients in the rituximab era.

Belotti A, Doni E, Bolis S, Rossini F, Casaroli I, Pezzatti S, Pogliani EM, Pioltelli PE.

Clin Lymphoma Myeloma Leuk. 2015 Apr;15(4):208-13. doi: 10.1016/j.clml.2014.10.001. Epub 2014 Oct 23.

PMID:
25468321
20.

Non transferrin bound iron (NTBI) in acute leukemias throughout conventional intensive chemotherapy: kinetics of its appearance and potential predictive role in infectious complications.

Belotti A, Duca L, Borin L, Realini S, Renso R, Parma M, Pioltelli P, Pogliani E, Cappellini MD.

Leuk Res. 2015 Jan;39(1):88-91. doi: 10.1016/j.leukres.2014.11.003. Epub 2014 Nov 15.

PMID:
25435028
21.

Validation of the classification criteria for cryoglobulinaemic vasculitis.

Quartuccio L, Isola M, Corazza L, Ramos-Casals M, Retamozo S, Ragab GM, Zoheir MN, El-Menyawi MA, Salem MN, Sansonno D, Ferraccioli G, Gremese E, Tzioufas A, Voulgarelis M, Vassilopoulos D, Scarpato S, Pipitone N, Salvarani C, Guillevin L, Terrier B, Cacoub P, Filippini D, Saccardo F, Gabrielli A, Fraticelli P, Sebastiani M, Tomsic M, Tavoni A, Mazzaro C, Pioltelli P, Nishimoto N, Scaini P, Zignego AL, Ferri C, Monti G, Pietrogrande M, Bombardieri S, Galli M, De Vita S.

Rheumatology (Oxford). 2014 Dec;53(12):2209-13. doi: 10.1093/rheumatology/keu271. Epub 2014 Jul 3.

PMID:
24994905
22.

Iron chelation therapy with deferasirox in the management of iron overload in primary myelofibrosis.

Elli EM, Belotti A, Aroldi A, Parma M, Pioltelli P, Pogliani EM.

Mediterr J Hematol Infect Dis. 2014 Jun 1;6(1):e2014042. doi: 10.4084/MJHID.2014.042. eCollection 2014.

23.

Impact of immunogenetic IL28B polymorphism on natural outcome of HCV infection.

De Re V, Gragnani L, Fognani E, Piluso A, Izzo F, Mangia A, Crovatto M, Gava G, Casarin P, Sansonno D, Racanelli V, De Vita S, Pioltelli P, Caggiari L, De Zorzi M, Berretta M, Gini A, Zucchetto A, Buonaguro FM, De Paoli P, Zignego AL.

Biomed Res Int. 2014;2014:710642. doi: 10.1155/2014/710642. Epub 2014 Feb 26.

24.

Lymph node hyperplasia: clonal chromosomal and genomic rearrangements. Report of two new cases and literature review.

Villa N, Redaelli S, Lissoni S, Saccheri F, Sala E, Crosti F, Dalprà L, Carrino V, Pioltelli P, Isimbaldi G.

Cancer Genet. 2014 Jan-Feb;207(1-2):12-8. doi: 10.1016/j.cancergen.2014.01.003. Epub 2014 Jan 16. Review.

PMID:
24636528
25.

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R.

Della Porta MG, Alessandrino EP, Bacigalupo A, van Lint MT, Malcovati L, Pascutto C, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Bernasconi P, Bosi A, Cazzola M, Rambaldi A; Gruppo Italiano Trapianto di Midollo Osseo.

Blood. 2014 Apr 10;123(15):2333-42. doi: 10.1182/blood-2013-12-542720. Epub 2014 Feb 20.

26.

Use of CXCR4-antagonist for haematopoietic stem cell mobilization in HIV-infected patients with haematological malignancies.

Bandera A, Verga L, Perseghin P, Incontri A, Pioltelli PE, Gori A.

AIDS. 2013 Mar 27;27(6):1037-9. doi: 10.1097/QAD.0b013e32835ecbcd. No abstract available.

PMID:
23698069
27.

Optimal timing of allogeneic hematopoietic stem cell transplantation in patients with myelodysplastic syndrome.

Alessandrino EP, Porta MG, Malcovati L, Jackson CH, Pascutto C, Bacigalupo A, Teresa van Lint M, Falda M, Bernardi M, Onida F, Guidi S, Iori AP, Cerretti R, Marenco P, Pioltelli P, Angelucci E, Oneto R, Ripamonti F, Rambaldi A, Bosi A, Cazzola M; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Am J Hematol. 2013 Jul;88(7):581-8. doi: 10.1002/ajh.23458. Epub 2013 May 30.

28.

Fludarabine, cyclophosphamide, and rituximab in salvage therapy of Waldenström's macroglobulinemia.

Tedeschi A, Ricci F, Goldaniga MC, Benevolo G, Varettoni M, Motta M, Pioltelli P, Gini G, Barate' C, Luraschi A, Vismara E, Frustaci AM, Nichelatti M, Vitolo U, Baldini L, Morra E.

Clin Lymphoma Myeloma Leuk. 2013 Apr;13(2):231-4. doi: 10.1016/j.clml.2013.02.011. Epub 2013 Mar 13.

PMID:
23490992
29.

Autologous mesenchymal stem cells as a new strategy in immunosuppressant therapy in double hand allotransplantation.

Del Bene M, Di Caprio AP, Melzi ML, Pioltelli PE, Bonomi S.

Plast Reconstr Surg. 2013 Feb;131(2):305e-307e. doi: 10.1097/PRS.0b013e318278d648. No abstract available.

PMID:
23358044
30.

Final results of a multicenter trial addressing role of CSF flow cytometric analysis in NHL patients at high risk for CNS dissemination.

Benevolo G, Stacchini A, Spina M, Ferreri AJ, Arras M, Bellio L, Botto B, Bulian P, Cantonetti M, Depaoli L, Di Renzo N, Di Rocco A, Evangelista A, Franceschetti S, Godio L, Mannelli F, Pavone V, Pioltelli P, Vitolo U, Pogliani EM; Fondazione Italiana Linfomi.

Blood. 2012 Oct 18;120(16):3222-8. doi: 10.1182/blood-2012-04-423095. Epub 2012 Aug 27.

31.

Performance of the preliminary classification criteria for cryoglobulinaemic vasculitis and clinical manifestations in hepatitis C virus-unrelated cryoglobulinaemic vasculitis.

Quartuccio L, Isola M, Corazza L, Maset M, Monti G, Gabrielli A, Tzioufas AG, Ferri C, Ferraccioli G, Ramos-Casals M, Voulgarelis M, Lenzi M, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Pioltelli P, Steinfeld S, Lamprecht P, Galli M, Bombardieri S, De Vita S.

Clin Exp Rheumatol. 2012 Jan-Feb;30(1 Suppl 70):S48-52. Epub 2012 May 14.

PMID:
22410397
32.

Circulating endothelial cells and endothelial activation in essential thrombocythemia: results from CD146+ immunomagnetic enrichment--flow cytometry and soluble E-selectin detection.

Belotti A, Elli E, Speranza T, Lanzi E, Pioltelli P, Pogliani E.

Am J Hematol. 2012 Mar;87(3):319-20. doi: 10.1002/ajh.22264. Epub 2011 Dec 21.

33.

A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis.

De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, Campanini M, Naclerio C, Tavoni A, Pietrogrande M, Ferri C, Mascia MT, Masolini P, Zabotti A, Maset M, Roccatello D, Zignego AL, Pioltelli P, Gabrielli A, Filippini D, Perrella O, Migliaresi S, Galli M, Bombardieri S, Monti G.

Arthritis Rheum. 2012 Mar;64(3):843-53. doi: 10.1002/art.34331.

34.

Iron overload and iron chelation therapy in patients with myelodysplastic syndrome treated by allogeneic stem-cell transplantation: report from the working conference on iron chelation of the Gruppo Italiano Trapianto di Midollo Osseo.

Alessandrino EP, Angelucci E, Cazzola M, Porta MG, Di Bartolomeo P, Gozzini A, Malcovati L, Pioltelli P, Sica S, Bosi A.

Am J Hematol. 2011 Oct;86(10):897-902. doi: 10.1002/ajh.22104. Epub 2011 Aug 2. No abstract available.

35.

Fludarabine plus cyclophosphamide and rituximab in Waldenstrom macroglobulinemia: an effective but myelosuppressive regimen to be offered to patients with advanced disease.

Tedeschi A, Benevolo G, Varettoni M, Battista ML, Zinzani PL, Visco C, Meneghini V, Pioltelli P, Sacchi S, Ricci F, Nichelatti M, Zaja F, Lazzarino M, Vitolo U, Morra E.

Cancer. 2012 Jan 15;118(2):434-43. doi: 10.1002/cncr.26303. Epub 2011 Jul 5.

36.

Preliminary classification criteria for the cryoglobulinaemic vasculitis.

De Vita S, Soldano F, Isola M, Monti G, Gabrielli A, Tzioufas A, Ferri C, Ferraccioli GF, Quartuccio L, Corazza L, De Marchi G, Ramos Casals M, Voulgarelis M, Lenzi M, Saccardo F, Fraticelli P, Mascia MT, Sansonno D, Cacoub P, Tomsic M, Tavoni A, Pietrogrande M, Zignego AL, Scarpato S, Mazzaro C, Pioltelli P, Steinfeld S, Lamprecht P, Bombardieri S, Galli M.

Ann Rheum Dis. 2011 Jul;70(7):1183-90. doi: 10.1136/ard.2011.150755. Epub 2011 May 13.

37.

Development of polycythemia vera after chemotherapy-induced remission of acute myeloid leukemia: a case report.

Belotti A, Doni E, Elli E, Rossi V, Pioltelli P, Pogliani EM.

Acta Haematol. 2011;126(1):52-3. doi: 10.1159/000324468. Epub 2011 Mar 31. No abstract available.

PMID:
21454967
38.

Recommendations for the management of mixed cryoglobulinemia syndrome in hepatitis C virus-infected patients.

Pietrogrande M, De Vita S, Zignego AL, Pioltelli P, Sansonno D, Sollima S, Atzeni F, Saccardo F, Quartuccio L, Bruno S, Bruno R, Campanini M, Candela M, Castelnovo L, Gabrielli A, Gaeta GB, Marson P, Mascia MT, Mazzaro C, Mazzotta F, Meroni P, Montecucco C, Ossi E, Piccinino F, Prati D, Puoti M, Riboldi P, Riva A, Roccatello D, Sagnelli E, Scaini P, Scarpato S, Sinico R, Taliani G, Tavoni A, Bonacci E, Renoldi P, Filippini D, Sarzi-Puttini P, Ferri C, Monti G, Galli M.

Autoimmun Rev. 2011 Jun;10(8):444-54. doi: 10.1016/j.autrev.2011.01.008. Epub 2011 Feb 15. Review.

39.

Reviewed diagnosis of primary and secondary immune thrombocytopenic purpura in 79 adult patients hospitalized in 2000-2002.

Cirasino L, Robino AM, Cattaneo M, Pioltelli PE, Pogliani EM, Morra E, Colombo P, Palmieri GA.

Blood Coagul Fibrinolysis. 2011 Jan;22(1):1-6. doi: 10.1097/MBC.0b013e3283401286.

PMID:
20962625
40.

Outcome of allogeneic stem cell transplantation following reduced-intensity conditioninig regimen in patients with idiopathic myelofibrosis: the g.I.T.m.o. Experience.

Patriarca F, Bacigalupo A, Sperotto A, Isola M, Bruno B, van Lint MT, Iori AP, Di Bartolomeo P, Musso M, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A.

Mediterr J Hematol Infect Dis. 2010 May 8;2(2):e2010010. doi: 10.4084/MJHID.2010.010.

41.

Prognostic impact of pre-transplantation transfusion history and secondary iron overload in patients with myelodysplastic syndrome undergoing allogeneic stem cell transplantation: a GITMO study.

Alessandrino EP, Della Porta MG, Bacigalupo A, Malcovati L, Angelucci E, Van Lint MT, Falda M, Onida F, Bernardi M, Guidi S, Lucarelli B, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Pascutto C, Oneto R, Pirolini L, Fanin R, Bosi A.

Haematologica. 2010 Mar;95(3):476-84. doi: 10.3324/haematol.2009.011429. Epub 2009 Nov 10.

42.

Appropriate hospital management of adult immune thrombocytopenic purpura patients in major Italian institutions in 2000-2002: a retrospective analysis.

Cirasino L, Robino AM, Cattaneo M, Pioltelli PE, Pogliani EM, Terranova L, Morra E, Colombo P, Palmieri GA, Piscitelli P.

Blood Coagul Fibrinolysis. 2010 Jan;21(1):77-84. doi: 10.1097/MBC.0b013e328332dbb6.

PMID:
19858712
43.

Management of poor peripheral blood stem cell mobilization: incidence, predictive factors, alternative strategies and outcome. A retrospective analysis on 2177 patients from three major Italian institutions.

Perseghin P, Terruzzi E, Dassi M, Baldini V, Parma M, Coluccia P, Accorsi P, Confalonieri G, Tavecchia L, Verga L, Ravagnani F, Iacone A, Pogliani EM, Pioltelli P.

Transfus Apher Sci. 2009 Aug;41(1):33-7. doi: 10.1016/j.transci.2009.05.011. Epub 2009 Jun 18.

PMID:
19540167
44.

Pegylated interferon-alpha2b plus ribavirin: an efficacious and well-tolerated treatment regimen for patients with hepatitis C virus related histologically proven cirrhosis.

Roffi L, Colloredo G, Pioltelli P, Bellati G, Pozzpi M, Parravicini P, Bellia V, Del Poggio P, Fornaciari G, Ceriani R, Ramella G, Corradi C, Rossini A, Bruno S; Gruppo Epatologico Lombardo.

Antivir Ther. 2008;13(5):663-73.

PMID:
18771050
45.

Allogeneic hematopoietic stem cell transplantation in myelofibrosis: the 20-year experience of the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Patriarca F, Bacigalupo A, Sperotto A, Isola M, Soldano F, Bruno B, van Lint MT, Iori AP, Santarone S, Porretto F, Pioltelli P, Visani G, Iacopino P, Fanin R, Bosi A; GITMO.

Haematologica. 2008 Oct;93(10):1514-22. doi: 10.3324/haematol.12828. Epub 2008 Aug 25.

46.

WHO classification and WPSS predict posttransplantation outcome in patients with myelodysplastic syndrome: a study from the Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Alessandrino EP, Della Porta MG, Bacigalupo A, Van Lint MT, Falda M, Onida F, Bernardi M, Iori AP, Rambaldi A, Cerretti R, Marenco P, Pioltelli P, Malcovati L, Pascutto C, Oneto R, Fanin R, Bosi A; Gruppo Italiano Trapianto di Midollo Osseo (GITMO).

Blood. 2008 Aug 1;112(3):895-902. doi: 10.1182/blood-2008-03-143735. Epub 2008 May 22.

47.

Ceftriaxone/Amikacin vs Ceftazidime/Amikacin as Empirical Therapy for Fever in Patients with Haematological Malignancy and Severe Granulocytopenia: Clinical and Economic Outcomes.

Rossini F, Pioltelli P, Bolis S, Borin L, Casaroli I, Lanzi E, Maffè P, Parma M, Tripputi P, Pogliani EM.

Clin Drug Investig. 1998;15(5):425-33.

PMID:
18370498
48.

Epidemiology and outcome of hepatocellular carcinoma in Lombardy.

Borzio M, Colloredo G, Pioltelli P, Quagliuolo M; Gruppo Epatologico Lombardo (GEL).

Dig Liver Dis. 2007 Nov;39(11):1011-7. Epub 2007 Oct 23.

PMID:
17936698
49.

Successful treatment with T-depleted autologous peripheral blood stem cell transplantation of refractory chronic autoimmune thrombocytopenic purpura.

Elli E, Parma M, Perseghin P, Dassi M, Terruzzi E, Belotti D, Pioltelli P, Poglian EM.

Haematologica. 2007 Jan;92(1):e7-8.

50.

CD34+ stem cell recovery after positive selection of "overloaded" immunomagnetic columns.

Perseghin P, Gaipa G, Dassi M, Belotti D, Pogliani EM, Pioltelli P, Balduzzi A, Rovelli A, Uderzo C, Biondi A.

Stem Cells Dev. 2005 Dec;14(6):740-3.

PMID:
16433629

Supplemental Content

Loading ...
Support Center